A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays

8.4K views

DOI:

10.3791/58710

January 7th, 2019

 ,  ,  ,  ,  ,  ,  , 

Corresponding Authors: Aniruddha J. Deshpande <adeshpande@SBPdiscovery.org>

In This Article

Summary

This manuscript describes a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) CRISPR-Cas9-based method for simple and expeditious investigation of the role of multiple candidate genes in Acute Myeloid Leukemia (AML) cell proliferation in parallel. This technique is scalable and can be applied in other cancer cell lines as well.

Abstract

Gene perturbation studies have been extensively used to investigate the role of individual genes in AML pathogenesis. For achieving complete gene disruption, many of these studies have made use of complex gene knockout models. While these studies with knockout mice offer an elegant and time-tested system for investigating genotype-to-phenotype relationships, a rapid and scalable method for assessing candidate genes that play a role in AML cell proliferation or survival in AML models will help accelerate the parallel interrogation of multiple candidate genes. Recent advances in genome-editing technologies have dramatically enhanced our ability to perform genetic perturbations at an unprecedented scale. One such system of genome editing is the CRISPR-Cas9-based method that can be used to make rapid and efficacious alterations in the target cell genome. The ease and scalability of CRISPR/Cas9-mediated gene-deletion makes it one of the most attractive techniques for the interrogation of a large number of genes in phenotypic assays. Here, we present a simple assay using CRISPR/Cas9 mediated gene-disruption combined with high-throughput flow-cytometry-based competition assays to investigate the role of genes that may play an important role in the proliferation or survival of human and murine AML cell lines.

Introduction

The past few decades have seen numerous research efforts focused on identifying the contribution of key molecular pathways in acute myeloid leukemia (AML) pathogenesis. Traditionally, gene-disruption in AML cells has been performed using conditional knockout mice or short-hairpin RNA (shRNA). While knockout mice offer a sophisticated system for spatio-temporal control of gene-deletion, generating gene knockout mice is labor-intensive, time-consuming and expensive. Furthermore, gene-knockouts using recombination strategies is not easily scalable; these strategies do not lend themselves well to the interrogation of several genes in parallel. After the discovery of RNA i....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Generating AML Cell Line Clones with High Expression of Stable and Active Cas9

  1. Production of Cas9 lentivirus
    1. Day 0: Plate 4 x 106 293T cells in 10 mL of DMEM with 10% fetal bovine serum (FBS) and penicillin and L-glutamine in a 10 cm tissue culture dish in a biosafety Level 2 (BSL2) certified cell culture hood. Place the dish in a 37 °C incubator.
    2. Day 1: The plated 293T cells should be 70–80% confluent on day 1. Perform the transfection using the following protocol in the afternoon.
    3. Warm the transfection medium, culture media and transfection reagent to room temperature. Thaw all t....

Access restricted. Please log in or start a trial to view this content.

Results

In our study, we first transduced the MOLM13 human AML cell line that bears the MLL-AF9 translocation with high-titer virus encoding the Cas9-blasticidin lentiviral plasmid. In our hands, bulk unsorted MOLM13-Cas9 cells did not display high level Cas9 expression by Western blotting and also did not perform well when assayed for efficient gene editing-using the method described previously7. Therefore, we proceeded to establish single cell clones and only select the .......

Access restricted. Please log in or start a trial to view this content.

Discussion

In this manuscript, we describe a detailed protocol for conducting a CRISPR-Cas9-based competitive growth assay to investigate the role of candidate genes in AML cell lines using flow-cytometry in human/murine AML cells (Figure 5). The goal of the assay is to identify the effect of gene deletion on maintenance of AML cell proliferation over two to three weeks on a medium-throughput scale. Some critical steps need to be followed carefully to facilitate the scaling up of the described protocol.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

A.J.D is a consultant to A2A pharmaceuticals (New Jersey) and Salgomed Therapeutics (San Diego). Other authors have no conflicts to declare.

Acknowledgements

The pCW-Cas9 plasmid was a gift from Eric Lander & David Sabatini (Addgene plasmid # 50661) and the pKLV2-U6gRNA5(BbsI)-PGKpuro2ABFP-W plasmid from the Yusa lab (Addgene plasmid #67974. We would like to thank the Flow Cytometry core at SBP Medical Discovery Institute for timely help with flow analysis and sorting. We would like to acknowledge the support of the Lady Tata Memorial Foundation to A.D. We would like to also acknowledge the support of the following funding sources: NIH/NCI P30 CA030199 Cancer Center Sponsored Grant, the V-Foundation and the San Diego NCI Cancer Centers (C3) #PTC2017to A.J.D.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
FLAG-M2 Antibodysigma-aldrichF3165, lot # SLBS3530V
Anti-mouse AntibodyInvitrogen31446, lot # TA2514341
SuperSignal West Femto Maximum Sensitivity SubstrateThermo Fisher34095
ChemiDoc Imaging SystemBIO RAD17001401
Sorvall Legend RT centrifugeThermo Scientific
BlasticidinThermo FisherR21001
SYTOX RedThermo FisherS34859
Opti-MEMThermo Fisher31985062
DMEMThermo Fisher11965-092
RPMIThermo Fisher11875-093
Penicillin-StreptomycinThermo Fisher15140122
L-Glutamine (200 mM)Thermo Fisher25030081
Fetal Bovine Serum (FBS)SAFC12303C
single gRNA vectorAddgene #67974pKLV2-U6gRNA5(BbsI)-PGKpuro2ABFP-W
CelLytic Nuclear extraction kitsigma-alorichNXTRACT
XtremeGENE 9sigma-alorich6365787001
RetronectinTakaraT100B
Flow cytometerBD Biosciences
T4 PNKNEBioLabsM0201S
T4 DNA ligation bufferNEBioLabsB0202S
T4 DNA Ligase enzymeNEBioLabsM0202S
AmpicillinFisher scientificBP1760-25
LB agarFisher scientificBP9724-500
LB BrothFisher scientificBP9731-500
Qiagen mini-prep kitQiagen27104
NanoDrop SpectrophotometerThermo FisherNanoDrop One
Recombinant Murine IL-3Peprotech213-13
Recombinant Murine IL-6Peprotech216-16
Recombinant Murine M-CSFPeprotech315-02
Stable competent cellsNEBiolabsC3040I
10 cm Tissue Culture dishesFisher Scientific353003
Cell lysis solutionQiagen158906
Protein precipitation solutionQiagen158910
DNA hydration solutionQiagen158914
QIAquick Gel Extraction KitQiagen28704
BbSINew England BioLabsR0539S
APEX 2.0x Taq Red Master Mix KitGenessee Scientific42-138
PuromycinFisher scientificBP2956100
50 mL polypropylene conical tubesFisher scientific1495949A
15 mL polypropylene conical tubesFisher scientific1495970C

References

  1. Mali, P., Esvelt, K. M., Church, G. M. Cas9 as a versatile tool for engineering biology. Nature Method. 10 (10), 957-963 (2013).
  2. Doudna, J. A., Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 346 (6213), 1258096(2014).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Flow CytometryCompetition AssayGene KnockoutAML Cell LinesSingle Guide RNALentiviral TransductionBFP Positive CellsFlow Cytometry Analysis